|
|
||||||||
in
cardiomyocytes
Department of Anesthesiology, University of North Carolina, Chapel Hill, North Carolina 27599
| |
ABSTRACT |
|---|
|
|
|---|
Oxygen
radicals and protein kinase C (PKC) mediate ischemic
preconditioning. Using a cultured chick embryonic cardiomyocyte model
of hypoxia and reoxygenation, we found that the oxygen radicals generated by ischemic preconditioning were
H2O2. Like preconditioning, H2O2 selectively activated the
-isoform of
PKC in the particulate compartment and increased cell viability after
1 h of hypoxia and 3 h of reoxygenation. The glutathione
peroxidase ebselen (converting H2O2 to
H2O) and the superoxide dismutase inhibitor
diethyldithiocarbamic acid abolished the increased
H2O2 and the protection of preconditioning. PKC
activation with phorbol 12-myristate 13-acetate increased cell
survival; the protection of preconditioning was blocked by
V1-2, a selective PKC-
antagonist.
Similar to preconditioning, the protection of PKC activation was
abolished by mitochondrial KATP channel blockade with
5-hydroxydecanoate or by GABA receptor stimulation with midazolam or
diazepam. In addition, PKC, mitochondrial ATP-sensitive K+
(KATP) channels, and GABA receptors had no effects on
H2O2 generated by ischemic
preconditioning before prolonged hypoxia and reoxygenation. We conclude
that H2O2 opens mitochondrial KATP
channels and inhibits GABA receptors via activating PKC-
. Through
this signal transduction, preconditioning protects ischemic cardiomyocytes.
-aminobutyric acid receptors; preconditioning
| |
INTRODUCTION |
|---|
|
|
|---|
OXYGEN RADICALS are important intracellular second messengers that mediate cardioprotection (7, 9). Preconditioning and flumazenil generate oxygen radicals and protect cardiomyocytes during ischemia-reperfusion (42). Flumazenil inhibits the GABA receptor complex (20). The GABA receptor antagonist is used clinically for reversal of apnea and loss of consciousness associated with oversedation (2) and might be beneficial in protecting against cerebral ischemia (20). Rapid administration of a GABA complex antagonist produces minimal coronary and left ventricular hemodynamic responses (24). GABA receptor antagonists might have a role in the management of patients with ischemic heart disease if they can mimic preconditioning to protect the heart and thus have cardiac protective properties. The first objective of our study was to examine the role of GABA receptors in the development of preconditioning protection.
GABA receptors have been identified in mitochondria (2, 19, 27, 28). Reactive oxygen species originating from mitochondria, ATP-sensitive K+ (KATP) channels, and protein kinase C (PKC) are second messengers in cardioprotection produced by hypoxic preconditioning, acetylcholine, opioids, and flumazenil (25, 31, 34, 37, 38). A second objective of this study was to examine the role of GABA receptors on preconditioning-induced oxygen radicals before the start of ischemia and to determine the sequence of GABA receptors, PKC, and oxygen radicals in the signal transduction pathway of ischemic preconditioning.
Cardiocyte injury in ischemia-reperfusion models correlates with the amount of free radicals produced (33), especially during the first few minutes of reperfusion (33, 43). Free radicals contribute to myocardial stunning, and the role of these radicals in lethal cell injury is unequivocal (16). Vanden Hoek et al. (33) demonstrated that in cultured cardiomyocytes, hypoxic preconditioning attenuated oxidant stress at reoxygenation. We hypothesize that ischemic preconditioning attenuates oxidant stress at hypoxia and reoxygenation and that GABA receptors play a role in development of this oxidant stress.
Finally, we wanted to determine the nature of oxygen radicals and which
isoform of PKC is important in mediating cardioprotection of
ischemic preconditioning. The findings of this study
demonstrate that in isolated cultured ventricular myocytes, hydrogen
peroxide/hydroxyl radicals inhibit mitochondrial GABA receptors
by activating the PKC-
isoform. Through this signal transduction
pathway, ischemic preconditioning protects cardiocytes during
hypoxia and reoxygenation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cardiomyocyte preparation. Ventricular myocytes from 10-day-old chick embryos were prepared according to a method described previously (3). Briefly, hearts were harvested and placed in Hanks' balanced salt solution lacking magnesium and calcium (Life Technologies; Grand Island, NY). Ventricles were minced, and myocytes were dissociated by use of trypsin degradation (0.025%, Life Technologies) repeated four to six times at 37°C with gentle agitation. Isolated cells were then transferred to a solution with trypsin inhibitor for 8 min, filtered through a 100-µm mesh filter, centrifuged for 5 min at 1,200 rpm at 4°C, and finally resuspended in a nutritive medium described previously (25). Resuspended cells were placed in a petri dish in a humidified incubator (5% CO2-95% air at 37°C) for 45 min to promote early adherence of fibroblasts. Nonadherent cells were counted with a hemocytometer, and viability was measured with trypan blue (0.4%). Approximately 1 × 106 cells in nutritive medium were pipetted onto coverslips (25 mm) and incubated for 3-4 days, after which synchronous contractions of the monolayer were noted. Experiments were performed on spontaneously contracting cells at day 3 or 4 after isolation.
Perfusion system. Glass coverslips containing spontaneously beating chick myocytes were placed in a stainless steel, 1-ml, flow-through chamber (Penn Century; Philadelphia, PA). The chamber was sealed with Kynar film (McMaster-Carr; Elmhurst, IL) placed between the coverslip and the metal hypoxic chamber to minimize oxygen exchange between the chamber wall and the perfusate and then mounted on a temperature-controlled platform (37°C) on an inverted microscope. A water-jacketed glass equilibration column mounted above the microscope stage was used to equilibrate the perfusate to known oxygen tensions (PO2). The standard perfusion medium was equilibrated for 1 h before the experiment by bubbling through it a gas mixture of 21% O2-5% CO2-74% N2. A hypoxia solution, composed of balanced salt solution (BSS) containing no glucose with 2-deoxyglucose (20 mmol/l) added to inhibit glycolysis, was bubbled with a gas mixture of 20% CO2 and 80% N2 for 1 h before the experiments. The pH of the perfusion solution was routinely verified [normoxic buffered salt solution (BSS) 7.4, simulated ischemia BSS 6.8]. Stainless steel or low oxygen solubility polymer tubing connected the equilibration column to the flow-through chamber to minimize ambient oxygen transfer into the perfusate. Hypoxic chamber PO2 was routinely monitored by Oxyspot (Medical Systems; Greenvale, NY) under conditions identical to those experiments using an optical phosphorescence quenching method (35).
Cell viability. An inverted microscope, equipped for epifluorescent illumination, included a xenon light source (75 W), a 12-bit digital, cooled CCD camera (Princeton Instruments), a shutter and filter wheel (Sutter), and appropriate excitation and emission filter cubes. The microscope was also equipped with Hoffman-modified phase illumination to accentuate surface topology and facilitate the measurement of contractile motion. Fluorescent cell images were obtained using a magnification of ×10 (Nikon Plan Fluor). Data were acquired and analyzed with Metamorph software (Universal Imaging). Cell viability was quantified with the nuclear stain propidium iodide (PI, 5 µM) (Molecular Probe; Eugene, OR), an exclusion fluorescent dye that binds to chromatin upon loss of membrane integrity (1, 4). PI is not toxic to cells over 8 h, permitting its addition to the perfusate throughout the experiments. At the completion of each experiment, digitonin (300 µM) was added to the perfusate for 1 h. Digitonin disrupts membrane integrity of all cells allowing a PI to enter all cells and thus permitting determination of the maximal value of PI (when all cells' membranes have been disrupted). Loss of viability (cell death) was then expressed as a percentage of the maximum value of PI after 1 h of digitonin exposure (100%).
Measurement of oxygen radicals. Oxygen radicals were assessed using the probe 2,7-dichlorofluorescin (DCFH). The membrane-permeable diacetate form of the dye DCFH (DCFH-DA) was added to the perfusate at a final concentration of 5 µM. Within the cell, esterases cleave the acetate groups on DCFH-DA, thus trapping the reduced probe (DCFH) intracellularly. Intracellular oxygen radicals lead to the oxidation of DCFH, yielding the fluorescent product DCF. The probe DCFH in cardiomyocytes is readily oxidized by H2O2 or hydroxyl radical but is relatively insensitive to superoxide. Fluorescence was measured using an excitation wavelength of 480 nm, dichroic 505-nm long pass, and emitter bandpass of 535 nm (Chroma Technology) with neutral density filters to attenuate the excitation light intensity. Fluorescence intensity was assessed in clusters of several cells identified as regions of interest. Background fluorescence was identified as an area without cells or with minimal cellular fluorescence. Intensity values are reported as percentage of initial values after the background value was subtracted.
PKC enzyme assay.
Enzyme activity of total PKC, PKC-
, and PKC-
isoforms was
measured by a method described previously (17, 26).
Briefly, 5 million cells for each experiment were collected in a sample buffer containing 50 mmol/l Tris · HCl (pH 7.5), 5 mmol/l EDTA, 10 mmol/l EGTA, 10 mmol/l benzamidine, 50 µg/ml phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml
pepstatin A, and 0.3%
-mercaptoethanol (Sigma; St. Louis, MO). The
collection was centrifuged at 45,000 g for 30 min and
separated into a cytosolic fraction and particulate fraction. The
particulate pellet was dissolved ultrasonically in the sample buffer.
Protein concentration was determined with the Bradford method
(5). Each fraction of 50-100 µg was assayed for
total PKC, PKC-
, and PKC-
activity using a kit (Amersham
Pharmacia; Piscataway, NJ). For PKC-
and PKC-
assays, the protein
was immunoprecipitated overnight by PKC-
and PKC-
monoclonal
antibody (BD Transduction Lab) in immunoprecipitation buffer (pH 7.4)
(150 mM NaCl, 50 mM Tris, 1 mM EGTA, 1 mM EDTA, 1% NP-40, 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 16 µg/ml
benzamidine-HCl, 10 µg/ml phenanthroline, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 10 µg/ml pepstatin A; Sigma) with protein A/G
beads (Santa Cruz Biotechnologies). In addition, PKC-
- or
-specific substrate (ERMRPRKRQGSVRRRV) (BioMol; Plymouth Meeting,
PA) was used for phosphorylation reaction with [32P]ATP
(Amersham Pharmacia; Piscataway, NJ).
Chemicals.
Midazolam was purchased from Roche Pharma (Humacao, PR), and diazepam
was purchased from Elkins-Sinn (Cherry Hill, NJ). PKC-
antagonist
(
V1-2) was purchased from Calbiochem-Novabiochem (San Diego, CA). Phorbol 12-myristate 13-acetate (PMA),
5-hydroxydecanoate (5-HD), ebselen, and diethyldithiocarbamic acid
(DDC) were purchased from Sigma. All agents were dissolved in BSS
buffer before administration. PI and DCFH-DA were purchased from
Molecular Probes (Eugene, OR). Rottlerin was purchased from BioMol
(Plymouth Meeting, PA) and dissolved in a 1:5 cocktail of
ethanol-saline.
V1-2, 5-HD,
ebselen, and DDC were chosen on the basis of our previous studies
(37, 42) and preliminary results in which these agents
were shown to almost completely abolish the beneficial effects of
ischemic preconditioning.
Statistical analysis. Data are expressed as means ± SE. Differences between groups for cell death and oxygen radical production were compared using a two-factor analysis of variance (ANOVA) with repeated measures and Fisher's least significant difference test. Differences between groups were considered significant when P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Effects of preconditioning on cell death, contraction, and oxidant
stress.
In this model of hypoxia and reoxygenation, preconditioning with 10 min
of hypoxia markedly reduced cell death. The pattern and extent of cell
death were similar to that previously reported (25, 42).
After 3 h of reoxygenation, cell death was 58.2 ± 7.3% in
controls (n = 8) and 15.8 ± 2.3% in
preconditioned cells (n = 8, P < 0.05)
(Fig.
1B).
At the end of 3 h of reoxygenation, visible contractile activity
was noticed in 14 of 16 preconditioned cells (87.5%) and 4 of 18 in
controls (22.2%, P < 0.05). Oxidant stress during
hypoxia and reoxygenation was lower in preconditioned cells (Fig.
1A). Therefore, preconditioning markedly attenuated oxidant
stress during hypoxia and reoxygenation and conferred protection from
cell death and contractile dysfunction.
|
GABA receptors, PKC, and mitochondrial KATP channels. The effects of preconditioning on reduced cell death and attenuated oxidant stress at hypoxia and reoxygenation were lost with the presence of GABA receptor agonists midazolam (100 µmol/l, 51.0 ± 6.5%, n = 6) or diazepam (100 µmol/l, 57.1 ± 8.1%, n = 7) versus controls (58.2 ± 7.3%, n = 8, P > 0.05). In contrast, a lower dose of midazolam or diazepam (10 µmol/l) had no effect on these beneficial effects of preconditioning. Midazolam or diazepam at a concentration of 100 µmol/l had no effect on cell death and oxidant stress compared with controls. Loss of GABA receptor activity is important in the cardioprotection of ischemic preconditioning.
The beneficial effects of ischemic preconditioning on reduced cell death and oxidant stress were lost in the presence of the specific PKC-
inhibitor (18)
V1-2 at 10 µmol/l (52.3 ± 3.4%, n = 8) or the selective
mitochondrial KATP channel blocker 5-HD at 100 µmol/l
(47.6 ± 6.4%, n = 7 vs. 58.2 ± 7.3%,
n = 8 in controls, P > 0.05).
V1-2 (10 µmol/l) and 5-HD (100 µmol/l) alone
had no effects on cell death compared with ischemic controls
(Figs. 3 and
4). Furthermore, rottlerin (3 µmol/l), which selectively antagonizes PKC-
at the dose <3
µmol/l, did not block the protection of preconditioning in our model.
|
|
|
Preconditioning generates H2O2, which
regulates GABA receptors and mitochondrial KATP channels
through PKC-
isoform.
Preconditioning increased DCFH oxidation, an index of oxygen radical
production, before prolonged hypoxia (Figs.
1A-4A). These results were consistent with
our previous finding (42). These oxygen radicals and
cardioprotection were abolished by DDC, an inhibitor for superoxide
dismutase (catalyzing O2 to H2O2)
or ebselen, a glutathione peroxidase that converts
H2O2 to H2O (Fig. 5). Like preconditioning,
H2O2 (5 µmol/l) also increased DCFH oxidation
and reduced cardiocyte death (Fig. 5).
|
V1-2, or 5-HD had no effect on
the oxygen radicals generated by preconditioning (Fig.
1A-4A). In addition, a higher dose of 5-HD
(1 mmol/l, n = 5) had no effect on
preconditioning-generated oxygen radicals. These results suggest that
ischemic preconditioning-induced oxygen radicals are not PKC,
mitochondrial KATP channels, or GABA receptor mediated.
Preconditioning and H2O2 (5 µmol/l) markedly
increased the enzyme activity of the PKC-
isoform in the particulate
fraction but had no effects on the enzyme activity of total PKC and
PKC-
isoform compared with controls. In the cytosolic fraction, no difference was observed in enzyme activity of total PKC, -
, or -
isoforms (Fig. 6).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In isolated cardiomyocytes, preconditioning increased cell survival and improved recovery of spontaneous contraction after hypoxia and reoxygenation. Large amounts of free radicals, assessed by DCFH oxidation, were detected during hypoxia and reoxygenation. Preconditioning attenuated this oxidant stress. GABA receptor agonists midazolam or diazepam abolished protection and restored oxidant stress. Thus preconditioning protects cardiocytes by attenuating oxidant stress through a GABA receptor-related mechanism.
GABA receptors and ischemic preconditioning. Ischemic preconditioning reduced cardiomyocyte death from hypoxia and reoxygenation. These results are consistent with our previous findings (38, 42) and those of others (21, 34). The GABA receptor antagonist flumazenil and preconditioning produced a similar protection (37, 42). Kochs et al. (20) showed that flumazenil protected against cerebral ischemic damage. The protection of preconditioning was abolished by GABA receptor stimulation with midazolam or diazepam. These observations suggest that loss of GABA receptor activity contributes to the development of preconditioning.
Hypoxia and reoxygenation generated a large amount of oxygen radicals that were attenuated by preconditioning (Fig. 1). Preconditioning decreases superoxide levels. Elevated endogenous manganese-superoxide dismutase (SOD) activity and increased SOD expression were found in rat cardiomyocytes 24 h after preconditioning ischemia (41). However, results of Turrens and co-workers (32) showed no changes of SOD, catalase, or glutathione peroxidase activities in preconditioned hearts. Controversy still exists regarding the role of endogenous antioxidant enzymes in preconditioning. Preconditioning preserves mitochondrial function in rat hearts and mitochondria from preconditioned hearts generate less superoxide radicals (36). Studies also suggest nonmitochondrial sources of free radicals are important in reperfusion injury (18). Antioxidants given during reperfusion protect cardiocytes to a similar degree as preconditioning (25, 33). The attenuated oxidant stress during the simulated ischemic period by preconditioning could slow down the depletion of endogenous antioxidants of cardiocytes, which would preserve the cells' ability to reduce oxidant stress at reoxygenation and result in increased survival. Thus a greater level of endogenous antioxidants as a result of preconditioning could be as important a mechanism of preconditioning as the reduced oxidant stress at reoxygenation for the cardioprotection of preconditioning. Free radicals, generated during both hypoxia and reoxygenation, contribute to the pathogenesis of cardiocyte damage. The mechanism by which free radicals damage cardiocytes is not established. The burst of free radical production at reoxygenation is transient and only lasts 15 min in our system. However, cell death constantly increases over the whole reoxygenation period. Free radicals, superoxide in particular, induce apoptosis (40). Therefore, apoptosis may play a role in progressive cell death during reoxygenation. GABA receptor stimulation with midazolam or diazepam abolished preconditioning and restored oxidant stress. These data indicate that loss of GABA receptor activity is important in preconditioning protection (reduced oxidant stress and cell death). The mechanism by which preconditioning inhibits GABA receptors hence attenuating oxidant stress is not established. GABA receptor complexes have been identified in mitochondria and have important function in regulating ion channels (2, 19), although the relationship of these ion channels to mitochondrial KATP channels needs to be defined. The dose of midazolam and diazepam used in this study is higher than expected, which suggest the GABA blockade with these compounds is at an intracellular site (such as mitochondria) rather than at the sarcolemmal membrane. Mitochondrial KATP channel opening attenuates oxidant stress at reoxygenation (33). In this study, blockade of mitochondrial KATP channels with 5-HD abolished the effects of preconditioning. Recently, Zhang and Yao (42) have showed that 5-HD did not affect GABA receptor antagonist flumazenil-generated oxygen radicals but abolished the protection of flumazenil. This study suggested that mitochondrial KATP channel opening was a downstream event of oxygen radicals and GABA complex. It seems reasonable to conclude that preconditioning leads to loss of mitochondrial GABA complex activity with resultant opening of mitochondrial KATP channels.Role of GABA receptors on oxygen radicals before prolonged hypoxia. Biological oxidants initiate intracellular signal transduction (25, 31). Preconditioning generated oxygen radicals before the prolonged hypoxia. Others (9, 34) have also reported that hypoxic preconditioning increased oxygen radicals in a similar myocyte model. Oxygen radicals are second messengers of preconditioning (7). Oxygen radicals also mediate the cardioprotection induced by transient hypoxia, acetylcholine, flumazenil, and opioids (9, 25, 34, 37).
GABA receptors, although not established in chick cardiomyocytes, have been found in mitochondria (2, 19, 28). Inhibition of these receptors affects various ion channels (19), has antistress activity (28), and regulates neurosteroidgenesis (27). Surprisingly, the GABA receptor agonist midazolam or diazepam had no effects on oxygen radicals produced by preconditioning before prolonged ischemia. Therefore, loss of GABA receptor activity seems to be a downstream event of oxygen radicals. The oxygen radicals generated by preconditioning are mainly H2O2 because DCFH is more readily oxidized by H2O2 and hydroxyl radicals than by superoxide radicals (8, 35). In addition, the radicals were abolished by ebselen, a glutathione peroxidase that converts H2O2 to H2O (8). The precursor of H2O2 is superoxide (O2·). SOD is an enzyme in the cytosol that catalyzes this reaction. DDC, a cytosol Cu,Zn-SOD inhibitor, attenuated the production of oxygen radicals. Thus preconditioning-generated oxygen radicals are H2O2 present in cytosol. Oxygen radicals generated by hypoxic preconditioning originate from mitochondria (34). Likely, free electrons (radicals) generated in mitochondria were transported to cytosol and converted to H2O2. More importantly, ebselen or DDC, which abolished preconditioning-generated H2O2 before prolonged hypoxia, blocked the beneficial effects of preconditioning. Thus H2O2 is important in mediating preconditioning. Yoshida and co-workers (39) showed that overexpression of glutathione peroxidase in mice increased myocardial tolerance to ischemia-reperfusion injury. Overexpression of glutathione peroxidase in mice results in increased antioxidant levels thus reducing free radical-related cardiac injury during ischemia-reperfusion. In the present study, ebselen was only given transiently before the prolonged hypoxia to prevent preconditioning-generated oxygen radicals and their downstream signal transduction. Ebselen was not present during prolonged hypoxia and reoxygenation and thus it had no antioxidant effects. How preconditioning produces H2O2 is not clear. A previous study by Vanden Hoek and colleagues (34) suggested that preconditioning generated superoxide inside mitochondria. Superoxide migrates into cytosol via anion channels. In cytosol, Cu,Zn-SOD converts superoxide to H2O2 and hydroxyl radicals.H2O2 activates the
-isoform of PKC and
mitochondrial KATP channels.
Preconditioning and H2O2 selectively activated
the
-isoform of PKC in the particulate fraction without changing its
activity in cytosol (Fig. 8). Activity of
total PKC and its
-isoform in both compartments was not affected by
preconditioning nor H2O2. The protective effect
of preconditioning was abolished by a specific PKC-
inhibitor
V1-2 but not by the selective PKC-
antagonist rottlerin (3 µmol/l). In a recent study from our laboratory, Zhang et
al. (23) showed that 1 µmol/l rottlerin abolished the
protection of opioid (23). Numerous studies (13, 14,
30) support the hypothesis that PKC is a central mediator of
preconditioning. In intact rats, inhibition of PKC could partially or
completely abolish the effects of preconditioning, depending on the
strength of preconditioning stimulus (14). Specific
isoforms of PKC are important, and translocation to mitochondrial
membrane of specific isoforms of PKC (
and
) is responsible for
preconditioning in rats and rabbits (17, 26). The fact
that rottlerin (3 µmol/l) did not significantly affect the protection
of preconditioning suggests that PKC-
is the key isoform in
mediating preconditioning in chick embryonic cardiomyocytes.
|
to mediate the protection of preconditioning.
The present results and our previous study (37, 42)
suggest activation of mitochondrial KATP channels is a
downstream event of oxygen radicals and PKC-
in mediating
cardioprotection of hypoxic preconditioning and flumazenil. However,
Forbes et al. (10) recently demonstrated that diazoxide, a
selective mitochondrial KATP channel opener, generates
oxygen radicals and protects ischemic rat hearts.
Acetylcholine, bradykinin, phenylephrine, and opioids generate oxygen
radicals that were blocked by selective mitochondrial KATP
channel antagonist 5-HD (6, 25, 38). These data indicate that the mitochondrial KATP channel is upstream of oxygen
radicals in mediating cardioprotection of these agents. Cohen et al.
(6) found that adenosine-induced cardioprotection was
independent of oxygen radicals. Taken together, although various
pharmacological agents, hypoxic and ischemic preconditioning,
all can protect hearts against ischemia-reperfusion injury,
they protect cardiomyocytes through different intracellular signal
transduction pathways.
In conclusion, in isolated chick cardiomyocytes, preconditioning
protection is associated with an attenuated oxidant stress. H2O2 produced by transient preconditioning
ischemia results in loss of mitochondrial GABA receptor
activity and opening of mitochondrial KATP channels via
activation of PKC-
isoform. Preconditioning exerts its protection
during hypoxia and reoxygenation through this signal transduction
pathway (Fig. 8).
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-03881, HL-70324, and HL-70325.
| |
FOOTNOTES |
|---|
10.1152/ajpheart.00683.2001
Address for reprint requests and other correspondence: Z. Yao, Dept. of Anesthesiology, Univ. of North Carolina at Chapel Hill, 223 Burnett-Womack Bldg., CB7010, Chapel Hill, NC 27599-7010 (E-mail: zyao{at}aims.unc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 August 2001; accepted in final form 20 November 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Altman, S,
Randers L,
and
Rao G.
Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations.
Biotech Prog
9:
671-674,
1993[Medline].
2.
Auta, J,
Romeo E,
Kozikowski A,
Ma D,
Costa E,
and
Guidotti A.
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
J Pharmacol Exp Ther
265:
649-656,
1993
3.
Barry, WH,
Pober J,
Marsh JD,
Frankel SR,
and
Smith TW.
Effects of graded hypoxia on contraction of cultured chick embryo ventricular cells.
Am J Physiol Heart Circ Physiol
239:
H651-H657,
1980.
4.
Bond, JM,
Herman B,
and
Lemasters JJ.
Recovery of cultured rat neonatal myocytes from hypercontracture after chemical hypoxia.
Res Commun Chem Pathol Pharmacol
71:
195-208,
1991[ISI][Medline].
5.
Bradford, MM.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem
72:
248-254,
1976[ISI][Medline].
6.
Cohen, MV,
Yang XM,
Liu GS,
Heusch G,
and
Downey JM.
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K.ATP channels.
Circ Res
89:
273-8,
2001
7.
Das, DK,
Engelman RM,
and
Maulik N.
Oxygen free radical signaling in ischemic preconditioning.
Ann NY Acad Sci
87:
49-65,
1999.
8.
Dikalov, S,
Khramtsov V,
and
Zimmer G.
Determination of rate constants of the reactions of thiols with superoxide radical by electron paramagnetic resonance: critical remarks on spectrophotometric approaches.
Arch Biochem Biophys
326:
207-218,
1996[ISI][Medline].
9.
Duranteau, J,
Chandel NS,
Kulisz A,
Shao Z,
and
Schumacker PT.
Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes.
J Biol Chem
273:
11619-11624,
1998
10.
Forbes, RA,
Steenbergen C,
and
Murphy E.
Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism.
Circ Res
88:
802-809,
2001
11.
Fryer, RM,
Schultz JJ,
Hsu AK,
and
Gross GJ.
Importance of PKC and tyrosine kinase in single of multiple cycles of preconditioning in rat hearts.
Am J Physiol Heart Circ Physiol
276:
H1229-H1235,
1999
12.
Garlid, K,
Paucek P,
Yarov-Yarovoy Murray HN Y,
Darbenzio RB,
D'Alonzo AJ,
Lodge NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
Circ Res
81:
1072-1082,
1997
13.
Gopalakrishna, R,
and
Anderson WB.
Ca2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain.
Proc Natl Acad Sci USA
86:
6578-6762,
1989.
14.
Goto, M,
Liu Y,
Yang XM,
Ardell JL,
Cohen MV,
and
Downey JM.
Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.
Circ Res
77:
611-621,
1995
15.
Gray, M,
Karliner JS,
and
Mochly-Rosen D.
A selective
-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death.
J Biol Chem
272:
30945-30951,
1997
16.
Jeroudi, MO,
Hartley CJ,
and
Bolli R.
Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidant.
Am J Cardiol
73:
2B-7B,
1994[Medline].
17.
Kawamura, S,
Yoshida K,
Miura T,
Mizukami Y,
and
Matsuzaki M.
ischemic preconditiong translocates PKC-
and -
which mediate functional protection in the isolated rat heart.
Am J Physiol Heart Circ Physiol
275:
H2266-H2271,
1998
18.
Kim, KS,
Takeda K,
Sethi R,
Pracyk JB,
Tanaka K,
Zhou YF,
Yu ZX,
Ferrans VJ,
Bruder JT,
Kovesdi I,
Irani K,
Goldschmidt-Clermont P,
and
Finkel T.
Protection from reoxygenation injury by inhibition of rac 1.
J Clin Invest
101:
1821-1826,
1998[ISI][Medline].
19.
Kinnally, KW,
Zorov DB,
Antonenko YN,
Snyder SH,
McEnery MW,
and
Tedeschi H.
Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands.
Proc Natl Acad Sci USA
90:
1374-1378,
1990
20.
Kochs, E,
Roewer N,
Peter A,
and
Schulte am Esch J.
Effect of flumazenil on global cerebral blood flow and on intracranial pressure in reperfusion phase following incomplete global cerebral ischemia.
Anasth Intensivther NotfallMed
23:
159-162,
1988[Medline].
21.
Liang, BT.
Protein kinase C-mediated preconditioning of cardiac myocytes: roles of adenosine receptor and KATP channel.
Am J Physiol Heart Circ Physiol
273:
H847-H853,
1997
22.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels; novel effectors or cardioprotection?
Circulation
97:
2463-2469,
1998
23.
Liu, H,
Zhang HY,
McPherson BC,
Baman T,
Roth S,
Shao Z,
Zhu X,
and
Yao Z.
Role of opioid
1 receptors, mitochondrial KATP channels, and protein kinase C during cardiocyte apoptosis.
J Mol Cell Cardiol
33:
2007-2014,
2001[ISI][Medline].
24.
Marty, J,
Nitenberg A,
Philip I,
Foult JM,
Joyon D,
and
Desmonts JM.
Coronary and left ventricular hemodynamic responses following reversal of flunitrazepam-induced sedation with flumazenil in patients with coronary artery disease.
Anesthesiology
74:
71-76,
1991[ISI][Medline].
25.
McPherson, BC,
and
Yao Z.
Morphine mimics preconditioning via free radical signals and mitochondrial KATP channels in myocytes.
Circulation
103:
290-295,
2001
26.
Ping, P,
Zhang J,
Qui Y,
Tang X,
Manchikalapudi S,
Cao X,
and
Bolli R.
ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.
Circ Res
81:
404-414,
1997
27.
Reddy, DS,
and
Kulkarni SK.
The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
Psychopharmacology (Berl)
137:
391-400,
1998[Medline].
28.
Romeo, E,
Cavallaro S,
Korneyev A,
Kozikowski A,
Ma D,
Polo A,
Costa E,
and
Guidotti A.
Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
J Pharmacol Exp Ther
267:
462-471,
1993
29.
Sato, T,
O'Rourke B,
and
Marban E.
Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C.
Circ Res
83:
110-114,
1998
30.
Simkhovich, BZ,
Przyklenk K,
and
Kloner RA.
Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review.
Cardiovasc Res
40:
9-22,
1998
31.
Suzuki, YJ,
Forman HJ,
and
Sevanian A.
Oxidants as stimulators of signal transduction.
Free Radic Biol Med
22:
269-285,
1997[ISI][Medline].
32.
Turrens, JF,
Thornton J,
Barnard ML,
Snyder S,
Liu G,
and
Downey JM.
Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant defenses.
Am J Physiol Heart Circ Physiol
262:
H585-H589,
1992
33.
Vanden Hoek, TL,
Becker LB,
Shao ZH,
Li CQ,
and
Schumacker PT.
Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion.
Circ Res
86:
541-548,
2000
34.
Vanden Hoek, TL,
Becker LB,
Shao Z,
Li C,
and
Schumacker PT.
Reactive oxygen species released from mitochondria during brief hypoxia induced preconditioning in cardiomyocytes.
J Biol Chem
273:
18092-18098,
1998
35.
Wilson, DF,
Rumsey WL,
Green TJ,
and
Vanderkooi JM.
The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration.
J Biol Chem
263:
2712-2718,
1988
36.
Yabe, K,
Nasa Y,
Sato M,
Iijima R,
and
Takeo S.
Preconditioning preserves mitochondrial function and glycolytic flux during an early period of reperfusion in perfused rat hearts.
Cardiovasc Res
33:
677-685,
1997
37.
Yao, Z,
McPherson BC,
Liu H,
Shao Z,
Li C,
Qin Y,
Vanden Hoek TL,
Becker LB,
and
Schumacker PT.
Signal transduction of flumazenil-induced preconditioning in myocytes.
Am J Physiol Heart Circ Physiol
280:
H1249-H1255,
2001
38.
Yao, Z,
Tong J,
Tan X,
Li C,
Shao Z,
Kim WC,
Vanden Hoek TL,
Becker LB,
Head CA,
and
Shumacker PT.
Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes.
Am J Physiol Heart Circ Physiol
277:
H2504-H2509,
1999
39.
Yoshida, T,
Watanabe M,
Engelman DT,
Engelman RM,
Schley JA,
Maulik N,
Ho YS,
Oberley TD,
and
Das DK.
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury.
J Mol Cell Cardiol
28:
1759-1767,
1996[ISI][Medline].
40.
Zamzami, N,
Marchetti P,
Castedo M,
Decaudin D,
Macho A,
Hirsch T,
Susin SA,
Petit PX,
Mignotte B,
and
Kroemer G.
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
J Exp Med
182:
367-377,
1995
41.
Zhai, X,
Zhou X,
and
Ashraf M.
Late ischemic preconditioning is mediated in myocytes by enhanced endogenous antioxidant activity stimulated by oxygen-derived free radicals.
Ann NY Acad Sci
793:
156-166,
1996[Medline].
42.
Zhang, Q,
and
Yao Z.
Role of reactive oxygen species and KATP channels in flumazenil-induced preconditioning effects in cardiomyocytes.
Am J Physiol Heart Circ Physiol
279:
H1858-H1863,
2000
43.
Zweier, JL,
Flaherty JT,
and
Weisfeldt ML.
Direct measurement of free radical generation following reperfusion of ischemic myocardium.
Proc Natl Acad Sci USA
84:
1404-1407,
1987
This article has been cited by other articles:
![]() |
F. Kolar, J. Jezkova, P. Balkova, J. Breh, J. Neckar, F. Novak, O. Novakova, H. Tomasova, M. Srbova, B. Ost'adal, et al. Role of oxidative stress in PKC-{delta} upregulation and cardioprotection induced by chronic intermittent hypoxia Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H224 - H230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inagaki, E. Churchill, and D. Mochly-Rosen Epsilon protein kinase C as a potential therapeutic target for the ischemic heart Cardiovasc Res, May 1, 2006; 70(2): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geracitano, A. Tozzi, N. Berretta, F. Florenzano, E. Guatteo, M. T. Viscomi, B. Chiolo, M. Molinari, G. Bernardi, and N. B Mercuri Protective role of hydrogen peroxide in oxygen-deprived dopaminergic neurones of the rat substantia nigra J. Physiol., October 1, 2005; 568(1): 97 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y.H. Woo, C. H.K. Cheng, and M. M.Y. Waye Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism Cardiovasc Res, January 1, 2005; 65(1): 244 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
T B Lindhardt, N Gadsboll, H Kelbaek, K Saunamaki, J K Madsen, P Clemmensen, B Hesse, and S Haunso Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function Heart, April 1, 2004; 90(4): 425 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nowak, D. Bakajsova, and G. L. Clifton Protein kinase C-{epsilon} modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells Am J Physiol Renal Physiol, February 1, 2004; 286(2): F307 - F316. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Remillard and J. X.-J. Yuan Activation of K+ channels: an essential pathway in programmed cell death Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L49 - L67. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gross and J. N. Peart KATP channels and myocardial preconditioning: an update Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H921 - H930. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Kevin, E. Novalija, M. L. Riess, A. K. S. Camara, S. S. Rhodes, and D. F. Stowe Sevoflurane Exposure Generates Superoxide but Leads to Decreased Superoxide During Ischemia and Reperfusion in Isolated Hearts Anesth. Analg., April 1, 2003; 96(4): 949 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Kevin, A. K. S. Camara, M. L. Riess, E. Novalija, and D. F. Stowe Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H566 - H574. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||